We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.18%
2 Technology 5.91%
3 Industrials 5.3%
4 Consumer Discretionary 4.44%
5 Healthcare 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASRV icon
4101
AmeriServ Financial
ASRV
$85M
$1K ﹤0.01%
227
-2,137
-90% -$6.56K
AWX icon
4102
Avalon Holdings
AWX
$10.8M
$1K ﹤0.01%
289
-479
-62% -$961
BBC icon
4103
Virtus Biotech Clinical Trials ETF
BBC
$50.2M
$1K ﹤0.01%
81
-100
-55% -$1.96K
BNTC icon
4104
Benitec Biopharma
BNTC
$431M
$1K ﹤0.01%
4
-1
-20% -$396
CASH icon
4105
Pathward Financial
CASH
$1.8B
$1K ﹤0.01%
69
-1,107
-94% -$18.1K
CBAN icon
4106
Colony Bankcorp
CBAN
$473M
$1K ﹤0.01%
124
-749
-86% -$7.12K
CDNA icon
4107
CareDx
CDNA
$2.34B
$1K ﹤0.01%
348
-308
-47% -$1.43K
CENN icon
4108
Cenntro
CENN
$8.63M
0
MBAI
4109
Check-Cap
MBAI
$9.63M
$1K ﹤0.01%
+1
New +$3.43K
CHNR icon
4110
China Natural Resources
CHNR
$5.24M
$1K ﹤0.01%
15
-8
-35% -$489
CIBR icon
4111
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.6B
$1K ﹤0.01%
+56
New +$947
CIG.C icon
4112
CEMIG Ordinary Shares
CIG.C
$8.12B
$1K ﹤0.01%
1,036
+901
+667% +$994
CNCR
4113
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
$1K ﹤0.01%
36
-24
-40% -$548
CNVS icon
4114
Cineverse
CNVS
$63.9M
$1K ﹤0.01%
+39
New +$1.32K
CPSH icon
4115
CPS Technologies
CPSH
$83.6M
$1K ﹤0.01%
499
-504
-50% -$934
CREG
4116
DELISTED
Smart Powerr
CREG
$1K ﹤0.01%
+1
New +$2.66K
CSBR icon
4117
Champions Oncology
CSBR
$70.4M
$1K ﹤0.01%
+488
New +$1.53K
CTAS icon
4118
Cintas
CTAS
$79.8B
$1K ﹤0.01%
+40
New +$921
CTMX icon
4119
CytomX Therapeutics
CTMX
$732M
$1K ﹤0.01%
138
-552
-80% -$6.3K
CZWI icon
4120
Citizens Community Bancorp
CZWI
$203M
$1K ﹤0.01%
105
-37
-26% -$352
ECPG icon
4121
Encore Capital Group
ECPG
$2.2B
$1K ﹤0.01%
34
-162
-83% -$4.16K
EDUC icon
4122
Educational Development Corp
EDUC
$11.8M
$1K ﹤0.01%
+200
New +$1.24K
ELS icon
4123
Equity Lifestyle Properties
ELS
$12.7B
$1K ﹤0.01%
32
-192
-86% -$6.97K
EPM icon
4124
Evolution Petroleum
EPM
$135M
$1K ﹤0.01%
+255
New +$1.38K
EUFN icon
4125
iShares MSCI Europe Financials ETF
EUFN
$4.31B
$1K ﹤0.01%
64
-691
-92% -$12.4K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 2.6% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.